Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
22
datasets available to search
ShareScore release 0.9.0
Dataset results
22 results for “Subjective liking”
GENEA Challenge 2023 Human-Likeness subjective evaluation data
<p>This repository contains human-likeness user-study response data and associated analyses from the GENEA Challenge 2023. The code was written by Gustav Eje Henter and is released under a Creative Commons Attribution 4.0 International (CC BY 4.0) license.</p> <p><strong>The archive contains:</strong><br> * This README.txt file.<br> * A LICENSE.txt file.<br> * A JSON file containing all human-likeness user-study responses included in the analyses.<br> * MATLAB .m files for reproducing the above analyses (both tables and figures).<br> * A folder called "output" that contains all files written by the analysis script, including .mat files with all the results computed by each analysis, as well as files created when compiling the final, pretty-looking pdf figures.<br> * A file output.txt that contains all output written to the MATLAB Command Window when running the analyses.</p> <p><strong>Requirements:</strong><br> * MATLAB and MATLAB Image Processing Toolbox<br> * distinguishable_colors.m by Timothy E. Holy (https://www.mathworks.com/matlabcentral/fileexchange/29702-generate-maximally-perceptually-distinct-colors)<br> * fragmaster by Augustin Martin Domingo and Tilman Vogel (https://ctan.org/pkg/fragmaster), a LaTeX utility<br> This was last tested on 2023-10-08 on MATLAB version 9.10.0.1739362 (R2021a) Update 5, running on macOS version 13.2 build 22D49.</p> <p><strong>To re-generate/reproduce</strong> the contents in the "output" folder:<br> 0. Ensure that all requirements are met.<br> 1. Run through the entire analysis script "run_analyses.m".<br> 2. Run the fragmaster command in the "output" folder.</p> <p><strong>Attribution:</strong><br> If you use this material in a scientific publication, please cite our latest paper on the GENEA Challenge 2023. At the time of writing (2023-10-08) this is our ACM ICMI 2023 paper. You can use the following BibTeX code to cite that work:<br> @inproceedings{kucherenko2023genea,<br> author={Kucherenko, Taras and Nagy, Rajmund and Yoon, Youngwoo and Woo, Jieyeon and Nikolov, Teodor and Tsakov, Mihail and Henter, Gustav Eje},<br> title={The {GENEA} {C}hallenge 2023: {A} large-scale evaluation of gesture generation models in monadic and dyadic settings},<br> booktitle = {Proceedings of the ACM International Conference on Multimodal Interaction},<br> publisher = {ACM},<br> series = {ICMI '23},<br> year={2023}<br> }</p> <p><strong>To find more</strong> GENEA Challenge 2023 material on the web, please see:<br> * https://svito-zar.github.io/GENEAchallenge2023/<br> * https://genea-workshop.github.io/2023/challenge/</p> <p><strong>If you have any questions</strong> or comments, please contact:<br> * Gustav Eje Henter <ghe@kth.se><br> * The GENEA Challenge organisers <genea-challenge@googlegroups.com></p>
Predicting subjective liking of bitter and sweet liquid solutions using facial electromyography: mixed model dataset
<p>Hedonic responses to foods are often measured using subjective liking ratings scales. This project investigated the potential use of electromyography as a means to predict subjective liking ratings using affective facial muscle activity recorded at different phases of oral processing while tasting liquids. Using linear mixed models, muscle activity recorded while emptying into the mouth, swirling, and thinking about the taste of bitter and sweet liquid solutions was used to predict subjective liking ratings. During different phases of the tasting, these mixed models demonstrate that zygomaticus major activity predicted increased liking and that corrugator supercilii and levator labii superioris predicted decreased liking. The change in liking ratings predicted by each muscle varied depending on whether participants were emptying, swirling, or thinking about the taste.</p>
A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy Subjects
ClinicalTrials.gov study NCT02798978. IPD Sharing: YES. Countries: 1. Publications: 1.
Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progr
ClinicalTrials.gov study NCT03061812. IPD Sharing: YES. Countries: 33. Publications: 2.
Effects of MDMA-like Substances in Healthy Subjects
ClinicalTrials.gov study NCT04847206. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)
ClinicalTrials.gov study NCT03145909. IPD Sharing: UNDECIDED. Countries: 4. Publications: 1.
Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer
ClinicalTrials.gov study NCT02674568. IPD Sharing: YES. Countries: 0. Publications: 1.
Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects
ClinicalTrials.gov study NCT00690170. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in
ClinicalTrials.gov study NCT02927262. IPD Sharing: YES. Countries: 21. Publications: 0.
Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution
ClinicalTrials.gov study NCT00776555. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exhausted-like CD8 T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects - sorted CD8 subsets
GEO Series GSE163731. Homo sapiens. 24 samples. Type: Expression profiling by high throughput sequencing.
Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects
ClinicalTrials.gov study NCT03682172. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease
ClinicalTrials.gov study NCT06175468. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight
ClinicalTrials.gov study NCT03018665. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor
ClinicalTrials.gov study NCT02365662. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma
ClinicalTrials.gov study NCT01881529. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies
ClinicalTrials.gov study NCT01788813. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects
ClinicalTrials.gov study NCT00884091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects
ClinicalTrials.gov study NCT01459276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genome wide expression from esophageal biopsies of subjects with EoE-like inflammatory diseases, eosinophilic esophagitis, gastroesophageal reflux disease and healthy controls
GEO Series GSE148381. Homo sapiens. 51 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.